PAULA LAHAYE: Open Payments
NPI 1033155684 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 46 payments from 20 companies in 2025. Trend: 2023 $69 · 2024 $697 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $189 |
| Inspire Medical Systems, Inc. | 3 | $154 |
| GlaxoSmithKline, LLC. | 7 | $140 |
| ABBVIE INC. | 5 | $94 |
| Lilly USA, LLC | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| PFIZER INC. | 2 | $42 |
| Eisai Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
Products named: INSPIRE, TRELEGY ELLIPTA, Ozempic, SYNTHROID, TZIELD, Wegovy, Leqembi, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
